Community/Retail

Clinically meaningful lowering of blood pressure through reduction in dietary sodium was achieved safely and rapidly in 1 week in a middle-aged and elderly cohort.

Elevated Lp(a), which was previously untreatable, may become treatable in the near future, according to the study investigator.

The SPRINT trial was the first to demonstrate the benefit of further reduction in blood pressure, but it included a limited Asian population and excluded patients with diabetes or history of stroke.

The SELECT trial expands on existing literature that have shown safety and cardiovascular benefit in individuals with diabetes to now also show benefit in obesity.

Specifying a day of the week to take the medication could help avoid inadvertent daily dosing

Tune in to this episode of Pharmacy Focus: Policy Edition for an update on the ever-evolving landscape of pharmacy reimbursements, pharmacy benefit manager reform, and direct and indirect remuneration fees.

The vaccine provides treatment prevention for individuals that are high risk of exposure to the chikungunya virus.

The sBLA was based on data from a clinical study assessing the pharmacokinetics of switching between adalimumab and adalimumab-bwwd for patients with moderate to severe plaque psoriasis.

Women with inflammation during COVID-19 infection are at higher risk for Long Covid symptoms, according to study results.

Pharmacists are accessible and trusted health care professionals who have an important role in supporting people living with mental illness.

More individuals with systemic lupus erythematosus treated with anifrolumab-fnia reached remission compared to the placebo.

Preventative drug lists were associated with a modest increase in adherence to combination inhaled corticosteroid long-acting β2-agonists.

Dr. Christina Madison, speaks with Dr. Jade Ranger, from the Prescription Shoppe in this episode of Public Health matters.

Tirzepatide is already approved under the brand name Mounjaro (Lilly) to be used along with diet and exercise to improve blood sugar in adults with type 2 diabetes.

Changes in gene expression could ultimately boost the production of inflammatory cytokines.

It's key for clinicians to optimize therapy prior to systemic agents.

More individuals who used e-cigarettes have reported pulmonary diseases compared with those who never smoked, including asthma.

Regular usage of cannabis may increase the risk of heart failure, stroke, or heart attack, even after adjusting for other cardiovascular disease risk factors.

TAK-279 is an investigational oral allosteric tyrosine kinase 2 inhibitor for active psoriatic arthritis.

Pricing is also a key issue, as many insurance plans do not cover these medications’ use for obesity.

With the rest of the retail world catching up with pharmacy queuing, will it change customer expectations at the counter?

With appointment-based models in community pharmacy, researchers have noted that community pharmacies are well suited for identifying and addressing social determinants of health.

Investigators found that there was no association of dementia incidence in insulin use at 5 years after stopping metformin and an association at 0.07 years for HbA1C level at year 1.

In May 2023, the FDA approved brexpiprazole as the first and only drug to receive approval for treatment of agitation associated with Alzheimer Disease dementia.

AI is expected to significantly quicken the pace of drug design and development, while improving the success rate of new medicines.

Pharmacists can play a vital role in educating patients about headaches and can help to limit their impact on the patient.

Treatment options for individuals impacted with PMS can vary and include lifestyle modifications, medication treatments, and herbal products.

Individuals that are younger in age, Black, have low levels of education, and low income were associated with a lower chance of getting the flu shot each year.

Ronna Hauser from the National Community Pharmacists Association (NCPA), discusses updates regarding reimbursement, pharmacy benefit manager (PBM) reforms, and direct and indirect remuneration (DIR) fees.

Understanding the mechanisms leading to weight loss could help identify potential benefits for cardiorenal health in patients with chronic kidney disease.